1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
  5. > Global Markets for Medical Imaging Reagents and Analysis Equipment -- Focus on Positron Emission Tomography

INTRODUCTION

STUDY OBJECTIVES

BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for medical imaging technologies, which includes both the imaging systems and the contrast agents. The key objective is to present a comprehensive analysis and future direction of imaging techniques as an important tool for the usage in medical diagnostic procedures.

This report explores present and future strategies within the medical imaging technology market, which includes X-ray imaging, ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography. The improvisation of the market as well as the setbacks and needs of the market are discussed in this report. The classifications, comparisons, advantages and disadvantages and usage of these types of diagnostic methods are also listed in this report.

A detailed analysis of medical imaging industry structure has been conducted. Revenues are broken down by the region and sales figures are estimated for the five-year period from 2011 through 2017.

Applications for medical imaging technologies are also discussed separately in the report, with an emphasis of the usage of the inhibitors in therapeutic categories and various disease sectors. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

Extensive research and new developments in the field of medical imaging technology has improved their usage in being able to be used as a prime diagnostic tool for various diseases and other medical conditions. Modern industries continue to explore the advantages of medical imaging technologies, leading to the steady market growth due to higher production of the imaging systems. This study is an update to the one published in January 2010.

R&D spending, along with increasing competition, new technologies, new advancements and new product launches have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors.

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type/ technology in light of new technologies, growing competition and changing customer needs.

CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE

This study contributes to the areas of market growth in medical imaging (imaging systems and contrast agents) product manufacturers and users. Pharmaceutical, biotechnical companies, research institutes, hospitals and physicians will find this study to be of interest.

SCOPE OF THE STUDY

The scope of this study encompasses imaging technology in the field of medicine. BCC analyzes each imaging market and its applications, regulatory environment, technology, market projections and market shares. Technological issues include the latest trends and developments. The emerging market for enzyme inhibitors includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand, among others.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers of imaging systems and contrast agents technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies were surveyed to obtain data for this study. Included were manufacturers and end users of medical imaging technologies in various types of disease sectors industries. Data were gathered from various industry sources. BCC spoke with officials within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

ABOUT THE AUTHOR

A team of professionals in the biotechnology industry carried out this study. The project manager is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has over 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are: Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.

The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in the life sciences. She has a number of research publications to her credit.

Table Of Contents

Global Markets for Medical Imaging Reagents and Analysis Equipment -- Focus on Positron Emission Tomography
TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION 1
STUDY OBJECTIVES 1
REASONS FOR DOING THIS STUDY 1
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE 1
SCOPE OF THE STUDY 2
METHODOLOGY 2
INFORMATION SOURCES 2
ABOUT THE AUTHOR 2
RELATED BCC RESEARCH REPORTS 3
BCC ONLINE SERVICES 3
DISCLAIMER 3
CHAPTER 2 SUMMARY 5
SUMMARY TABLE GLOBAL REVENUE OF MEDICAL IMAGING MARKET, THROUGH 2017 ($
MILLIONS) 6
SUMMARY FIGURE GLOBAL REVENUE OF MEDICAL IMAGING MARKET, 2010-2017 ($
MILLIONS) 6
CHAPTER 3 OVERVIEW 8
DEFINITIONS 8
TYPES OF MEDICAL IMAGING 8
X-RAY IMAGING 8
History and Development of X-ray Imaging 9
TABLE 1 HISTORY AND DEVELOPMENT OF X-RAY IMAGING 9
Properties of X-ray 10
Applications of X-ray in Medicine 10
Advantages and Disadvantages of X-ray 11
TABLE 2 ADVANTAGES AND DISADVANTAGES OF X-RAY 11
ULTRASOUND 11
History and Development of Ultrasound 12
TABLE 3 HISTORY AND DEVELOPMENT OF ULTRASOUND 12
Diagnostic Applications of Ultrasound 13
Therapeutic Applications of Ultrasound 13
Advantages and Disadvantages of Ultrasound 14
TABLE 4 ADVANTAGES AND DISADVANTAGES OF ULTRASOUND 14
MAGNETIC RESONANCE IMAGING 14
History and Development of Magnetic Resonance Imaging 15
TABLE 5 HISTORY AND DEVELOPMENT OF MRI 15
Applications of Magnetic Resonance Imaging 15
Advantages and Disadvantages of MRI 16
TABLE 6 ADVANTAGES AND DISADVANTAGES OF MRI 16
COMPUTED TOMOGRAPHY 16
Applications of Computed Tomography 17
Advantages and Disadvantages of Computed Tomography 18
TABLE 7 ADVANTAGES AND DISADVANTAGES OF COMPUTED TOMOGRAPHY 18
POSITRON EMISSION TOMOGRAPHY 18
History and Development of Positron Emission Technology 19
TABLE 8 HISTORY AND DEVELOPMENT OF POSITRON EMISSION TECHNOLOGY 19
Advantages and Disadvantages of PET 20
TABLE 9 ADVANTAGES AND DISADVANTAGES OF PET 20
COMPARISON OF VARIOUS IMAGING MODALITIES 21
TABLE 10 DIFFERENCES BETWEEN CT AND MRI 21
TABLE 11 DIFFERENCES BETWEEN CT AND ULTRASOUND 22
TABLE 12 DIFFERENCES BETWEEN CT AND PET 22
TABLE 13 DIFFERENCES BETWEEN MRI AND X-RAY 23
CONTRAST AGENTS 23
PROPERTIES OF AN IDEAL CONTRAST AGENT 23
UNDESIRABLE EFFECTS OF CONTRAST AGENTS 23
Allergic Reactions 23
Acute Renal Failure 24
Aspiration 24
Pulmonary Edema 24
Seizure 24
CLASSIFICATION OF CONTRAST AGENTS BASED ON THEIR PROPERTIES 24
Positive Contrast Agents 24
Negative Contrast Agents 24
CLASSIFICATION OF CONTRAST AGENTS BASED ON THE TYPE OF IMAGING
TECHNIQUE 25
Contrast Agents for X-ray 25
TABLE 14 ADVANTAGES AND DISADVANTAGES OF BARIUM AS CONTRAST MEDIUM 25
Contrast Agents for Magnetic Resonance Imaging 26
Nonspecific Extracellular Agents 26
TABLE 15 NONSPECIFIC EXTRACELLULAR CONTRAST AGENTS 26
Tissue-Specific Contrast Agents 27
TABLE 16 LIVER-SPECIFIC CONTRAST AGENTS 27
Contrast Agents for Ultrasound 27
PET Radiopharmaceuticals 28
TABLE 17 COMMONLY USED RADIOPHARMACEUTICALS 28
IMAGING EQUIPMENT 29
X-RAY IMAGING SYSTEM 29
FLUOROSCOPY EQUIPMENT 30
COMPUTED TOMOGRAPHY SCANNER 30
Types of Computed Tomography Scanning 30
Advances in CT Scanners /Types of CT Scanners 30
ULTRASOUND MACHINES 31
MAGNETIC RESONANCE IMAGING SYSTEM 32
POSITRON EMISSION TOMOGRAPHY EQUIPMENT 33
CHAPTER 4 REGULATORY ISSUES 35
APPROVALS IN THE FIELD OF MEDICAL IMAGING 35
NEW APPROVALS 35
TABLE 18 NEW APPROVAL OF IMAGING SYSTEMS, 2008-AUGUST 2012 35
510(K) APPROVALS 36
TABLE 19 510(K) APPROVALS FOR ULTRASOUND SYSTEMS, 2008-AUGUST 2012 36
TABLE 20 510(K) APPROVALS FOR MRI SYSTEMS, 2008-AUGUST 2012 42
TABLE 21 510(K) APPROVALS FOR X-RAY/CT SYSTEMS, 2008-AUGUST 2012 43
TABLE 22 510(K) APPROVALS FOR PET SYSTEMS, 2008-AUGUST 2012 46
RECALLS 46
TABLE 23 RECALLS FOR MAGNETIC RESONANCE IMAGING SYSTEMS 46
TABLE 24 RECALLS FOR X-RAY AND COMPUTED TOMOGRAPHY SYSTEMS,
2008—SEPTEMBER 2012 48
TABLE 25 RECALLS FOR ULTRASOUND SYSTEMS, 2008-SEPTEMBER 2012 52
TABLE 26 RECALLS FOR PET SYSTEMS, 2008—SEPTEMBER 2012 56
APPROVALS FOR CONTRAST AGENTS 57
TABLE 27 APPROVAL OF CONTRAST AGENTS 58
SAFETY ALERTS 59
TABLE 28 SAFETY ALERTS FOR CONTRAST AGENTS, 2008—SEPTEMBER 2012 59
CHAPTER 5 NEW DEVELOPMENTS/ TECHNOLOGICAL INNOVATIONS 62
TABLE 29 NEW DEVELOPMENTS IN CONTRAST AGENTS 62
TABLE 30 NEW DEVELOPMENTS IN COMPUTED TOMOGRAPHY 62
TABLE 31 NEW DEVELOPMENTS IN MAGNETIC RESONANCE IMAGING 63
TABLE 32 NEW DEVELOPMENTS IN POSITRON EMISSION TOMOGRAPHY 63
TABLE 33 NEW DEVELOPMENTS IN ULTRASOUND 64
TABLE 34 NEW DEVELOPMENTS IN RADIOGRAPHY (X-RAY, MAMMOGRAPHY AND
FLUOROSCOPY) 66
CHAPTER 6 GLOBAL MARKET ANALYSIS FOR IMAGING TECHNOLOGIES 68
MARKET FOR CONTRAST AGENTS BY IMAGING TECHNOLOGY 69
MARKET OVERVIEW 69
MARKET REVENUE 71
TABLE 35 GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY,
THROUGH 2017 ($ MILLIONS) 71
FIGURE 1 GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY,
2010-2017 ($ MILLIONS) 71
MARKET SHARE 72
TABLE 36 GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY
2011 (%) 72
FIGURE 2 GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY,
2011 (%) 72
MARKET FOR IMAGING SYSTEMS BY IMAGING TECHNOLOGY 73
MARKET OVERVIEW 73
MARKET REVENUE 76
TABLE 37 GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, THROUGH
2017 ($ MILLIONS) 77
FIGURE 3 GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2010-2017
($ MILLIONS) 77
MARKET SHARE 77
TABLE 38 MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011 (%) 78
FIGURE 4 MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011 (%) 78
GLOBAL MARKET FOR CONTRAST AGENTS BY REGION 78
MARKET OVERVIEW 79
MARKET REVENUE 81
TABLE 39 GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, THROUGH 2017 ($
MILLIONS) 81
FIGURE 5 GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, 2010-2017 ($ MILLIONS) 81
MARKET SHARE 82
TABLE 40 GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011 (%) 82
FIGURE 6 GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011 (%) 82
MARKET FOR IMAGING SYSTEMS BY REGION 82
MARKET OVERVIEW 83
MARKET REVENUE 85
TABLE 41 GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, THROUGH 2017 ($
MILLIONS) 86
FIGURE 7 GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, 2010-2017 ($ MILLIONS) 86
MARKET SHARE 86
TABLE 42 GLOBAL MARKET SHARES FOR IMAGING SYSTEMS, BY REGION, 2011 (%) 87
FIGURE 8 GLOBAL MARKET SHARE FOR IMAGING SYSTEMS BY REGION, 2011 (%) 87
MARKET BY APPLICATIONS 87
TABLE 43 GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR
VARIOUS DISEASES, THROUGH 2017 ($ MILLIONS) 92
FIGURE 9 GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR
VARIOUS DISEASES, 2010-2017 ($ MILLIONS) 92
MARKET SHARE 93
TABLE 44 GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND
SYSTEMS USED FOR VARIOUS DISEASES, 2011 (%) 94
FIGURE 10 GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND
SYSTEMS USED FOR VARIOUS DISEASES, 2011 (%) 94
CHAPTER 7 MARKET FOR POSITRON EMISSION TOMOGRAPHY 96
MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION 96
MARKET OVERVIEW 96
MARKET REVENUE 98
TABLE 45 GLOBAL MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION,
THROUGH 2017 ($ MILLIONS) 98
FIGURE 11 GLOBAL MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION,
2010-2017 ($ MILLIONS) 98
MARKET SHARE 99
TABLE 46 MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, 2011
(%) 99
FIGURE 12 MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, 2011
(%) 99
MARKET FOR IMAGING SYSTEMS BY REGION 100
MARKET OVERVIEW 100
MARKET REVENUE 101
TABLE 47 GLOBAL MARKET FOR PET SYSTEMS, BY REGION, THROUGH 2017 ($ MILLIONS) 101
FIGURE 13 GLOBAL MARKET FOR PET SYSTEMS, BY REGION, 2010-2017 ($ MILLIONS) 101
MARKET SHARE 102
TABLE 48 MARKET SHARE OF PET SYSTEMS BY REGION, 2011 (%) 102
FIGURE 14 MARKET SHARE OF PET SYSTEMS BY REGION, 2011 (%) 102
MARKET BY APPLICATIONS 102
TABLE 49 GLOBAL REVENUE FOR PET IMAGING USED FOR VARIOUS DISEASES, THROUGH
2017 ($ MILLIONS) 104
FIGURE 15 GLOBAL REVENUE FOR PET IMAGING USED FOR VARIOUS DISEASES, 2010-2017
($ MILLIONS) 104
MARKET SHARE 105
TABLE 50 POSITRON EMISSION TOMOGRAPHY IMAGING MARKET SHARES, BY
APPLICATION, 2011 (%) 105
FIGURE 16 POSITRON EMISSION TOMOGRAPHY IMAGING MARKET SHARES, BY
APPLICATION, 2011 (%) 105
INDUSTRY STRUCTURE 106
RADIOPHARMACEUTICALS 106
Market Leaders 106
TABLE 51 LEADING MANUFACTURERS OF DIAGNOSTIC RADIOPHARMACEUTICALS 107
Market Share 109
TABLE 52 WORLDWIDE MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS, 2011
(%) 109
FIGURE 17 WORLDWIDE MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS,
2011 (%) 109
POSITRON EMISSION TOMOGRAPHY SYSTEMS 110
Market Leaders 110
TABLE 53 LEADING MANUFACTURERS OF PET IMAGING SYSTEMS 110
Market Share 111
TABLE 54 WORLDWIDE MARKET SHARES OF PET IMAGING SYSTEMS, 2011 (%) 111
FIGURE 18 WORLDWIDE MARKET SHARES OF PET IMAGING SYSTEMS, 2011 (%) 111
CHAPTER 8 PATENT ANALYSIS 113
CONTRAST AGENTS 113
BY YEAR 113
TABLE 55 TOTAL NUMBER OF PATENTS FOR CONTRAST AGENTS, FROM 2008-JULY 2012 113
BY IMAGING MODALITY 113
TABLE 56 NUMBER OF PATENTS FOR CONTRAST AGENTS BY IMAGING MODALITY, FROM
2008-JULY 2012 114
BY COMPANY 114
TABLE 57 NUMBER OF PATENTS BY COMPANY FROM 2008-JULY 2012 114
BY COUNTRY 114
TABLE 58 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 115
BY ASSIGNEE 115
TABLE 59 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 115
IMAGING SYSTEMS 115
BY YEAR 115
TABLE 60 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012 116
FIGURE 19 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012 116
FIGURE 20 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012
(%) 116
BY IMAGING MODALITY 117
TABLE 61 NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012 117
FIGURE 21 NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012 117
BY COMPANY 117
TABLE 62 NUMBER OF PATENTS BY COMPANY FROM 2008-JULY 2012 118
BY COUNTRY 119
TABLE 63 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 120
FIGURE 22 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 120
BY ASSIGNEE 121
TABLE 64 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 121
FIGURE 23 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 121
CHAPTER 9 DEMAND AND USE 123
CONTRAST AGENTS MARKET 123
REGULATORY ISSUES 123
BABY BOOMER GENERATION 123
INCREASING INCIDENCE OF LIFE-THREATENING DISEASES 123
COMPETITION 124
TECHNOLOGICAL ADVANCEMENTS 124
SETBACKS IN INDUSTRY 124
TRENDS IN THE IMAGING SYSTEMS MARKET 124
CHAPTER 10 COMPANY PROFILES 128
AMAG PHARMACEUTICALS INC. 128
ANALOGIC CORPORATION 128
BAYER HEALTHCARE PHARMACEUTICALS 129
BRACCO IMAGING SPA 129
COVIDIEN 129
ECHOSON SA (PL) 130
ESAOTE S.P.A 130
FONAR CORPORATION 131
GE HEALTHCARE 131
GUERBET LLC 132
HITACHI MEDICAL CORPORATION 132
HOLOGIC INC 133
LANTHEUS MEDICAL IMAGING 133
MILLENIUM TECHNOLOGIES LTD. 133
NORDION 134
PARADIGM MEDICAL INDUSTRIES INC. 134
PARAMED MEDICAL SYSTEMS INC. 135
PHILIPS HEALTHCARE 135
POSITRON CORPORATION 135
SAMSUNG MEDISON AMERICA INC 136
SHIMADZU CORPORATION 136
SIEMENS AG 137
SONOSITE INC 137
TELEMED LTD. 138
TERASON ULTRASOUND 138
TIME MEDICAL INC. 139
TOMTEC IMAGING SYSTEMS 139
TOSHIBA MEDICAL SYSTEMS CORPORATIONS 140
TRIAD ISOTOPES INC. 140
ULTRASONIX MEDICAL CORP. 140
VOLCANO CORPORATION 141
ZONARE MEDICAL SYSTEMS INC. 141
CHAPTER 11 APPENDIX I-ABBREVIATIONS 144

LIST OF TABLES
SUMMARY TABLE GLOBAL REVENUE OF MEDICAL IMAGING MARKET, THROUGH 2017 ($
MILLIONS) 6
TABLE 1 HISTORY AND DEVELOPMENT OF X-RAY IMAGING 9
TABLE 2 ADVANTAGES AND DISADVANTAGES OF X-RAY 11
TABLE 3 HISTORY AND DEVELOPMENT OF ULTRASOUND 12
TABLE 4 ADVANTAGES AND DISADVANTAGES OF ULTRASOUND 14
TABLE 5 HISTORY AND DEVELOPMENT OF MRI 15
TABLE 6 ADVANTAGES AND DISADVANTAGES OF MRI 16
TABLE 7 ADVANTAGES AND DISADVANTAGES OF COMPUTED TOMOGRAPHY 18
TABLE 8 HISTORY AND DEVELOPMENT OF POSITRON EMISSION TECHNOLOGY 19
TABLE 9 ADVANTAGES AND DISADVANTAGES OF PET 20
TABLE 10 DIFFERENCES BETWEEN CT AND MRI 21
TABLE 11 DIFFERENCES BETWEEN CT AND ULTRASOUND 22
TABLE 12 DIFFERENCES BETWEEN CT AND PET 22
TABLE 13 DIFFERENCES BETWEEN MRI AND X-RAY 23
TABLE 14 ADVANTAGES AND DISADVANTAGES OF BARIUM AS CONTRAST MEDIUM 25
TABLE 15 NONSPECIFIC EXTRACELLULAR CONTRAST AGENTS 26
TABLE 16 LIVER-SPECIFIC CONTRAST AGENTS 27
TABLE 17 COMMONLY USED RADIOPHARMACEUTICALS 28
TABLE 18 NEW APPROVAL OF IMAGING SYSTEMS, 2008-AUGUST 2012 35
TABLE 19 510(K) APPROVALS FOR ULTRASOUND SYSTEMS, 2008-AUGUST 2012 36
TABLE 20 510(K) APPROVALS FOR MRI SYSTEMS, 2008-AUGUST 2012 42
TABLE 21 510(K) APPROVALS FOR X-RAY/CT SYSTEMS, 2008-AUGUST 2012 43
TABLE 22 510(K) APPROVALS FOR PET SYSTEMS, 2008-AUGUST 2012 46
TABLE 23 RECALLS FOR MAGNETIC RESONANCE IMAGING SYSTEMS 46
TABLE 24 RECALLS FOR X-RAY AND COMPUTED TOMOGRAPHY SYSTEMS, 2008—SEPTEMBER
2012 48
TABLE 25 RECALLS FOR ULTRASOUND SYSTEMS, 2008-SEPTEMBER 2012 52
TABLE 26 RECALLS FOR PET SYSTEMS, 2008—SEPTEMBER 2012 56
TABLE 27 APPROVAL OF CONTRAST AGENTS 58
TABLE 28 SAFETY ALERTS FOR CONTRAST AGENTS, 2008—SEPTEMBER 2012 59
TABLE 29 NEW DEVELOPMENTS IN CONTRAST AGENTS 62
TABLE 30 NEW DEVELOPMENTS IN COMPUTED TOMOGRAPHY 62
TABLE 31 NEW DEVELOPMENTS IN MAGNETIC RESONANCE IMAGING 63
TABLE 32 NEW DEVELOPMENTS IN POSITRON EMISSION TOMOGRAPHY 63
TABLE 33 NEW DEVELOPMENTS IN ULTRASOUND 64
TABLE 34 NEW DEVELOPMENTS IN RADIOGRAPHY (X-RAY, MAMMOGRAPHY AND
FLUOROSCOPY) 66
TABLE 35 GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, THROUGH
2017 ($ MILLIONS) 71
TABLE 36 GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY
2011 (%) 72
TABLE 37 GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, THROUGH
2017 ($ MILLIONS) 77
TABLE 38 MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011 (%) 78
TABLE 39 GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, THROUGH 2017 ($
MILLIONS) 81
TABLE 40 GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011 (%) 82
TABLE 41 GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, THROUGH 2017 ($
MILLIONS) 86
TABLE 42 GLOBAL MARKET SHARES FOR IMAGING SYSTEMS, BY REGION, 2011 (%) 87
TABLE 43 GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR
VARIOUS DISEASES, THROUGH 2017 ($ MILLIONS) 92
TABLE 44 GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND
SYSTEMS USED FOR VARIOUS DISEASES, 2011 (%) 94
TABLE 45 GLOBAL MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION,
THROUGH 2017 ($ MILLIONS) 98
TABLE 46 MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, 2011 (%) 99
TABLE 47 GLOBAL MARKET FOR PET SYSTEMS, BY REGION, THROUGH 2017 ($ MILLIONS) 101
TABLE 48 MARKET SHARE OF PET SYSTEMS BY REGION, 2011 (%) 102
TABLE 49 GLOBAL REVENUE FOR PET IMAGING USED FOR VARIOUS DISEASES, THROUGH
2017 ($ MILLIONS) 104
TABLE 50 POSITRON EMISSION TOMOGRAPHY IMAGING MARKET SHARES, BY APPLICATION,
2011 (%) 105
TABLE 51 LEADING MANUFACTURERS OF DIAGNOSTIC RADIOPHARMACEUTICALS 107
TABLE 52 WORLDWIDE MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS, 2011
(%) 109
TABLE 53 LEADING MANUFACTURERS OF PET IMAGING SYSTEMS 110
TABLE 54 WORLDWIDE MARKET SHARES OF PET IMAGING SYSTEMS, 2011 (%) 111
TABLE 55 TOTAL NUMBER OF PATENTS FOR CONTRAST AGENTS, FROM 2008-JULY 2012 113
TABLE 56 NUMBER OF PATENTS FOR CONTRAST AGENTS BY IMAGING MODALITY, FROM
2008-JULY 2012 114
TABLE 57 NUMBER OF PATENTS BY COMPANY FROM 2008-JULY 2012 114
TABLE 58 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 115
TABLE 59 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 115
TABLE 60 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012 116
TABLE 61 NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012 117
TABLE 62 NUMBER OF PATENTS BY COMPANY FROM 2008-JULY 2012 118
TABLE 63 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 120
TABLE 64 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 121

LIST OF FIGURES
SUMMARY FIGURE GLOBAL REVENUE OF MEDICAL IMAGING MARKET, 2010-2017 ($
MILLIONS) 6
FIGURE 1 GLOBAL MARKET FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY, 2010-2017
($ MILLIONS) 71
FIGURE 2 GLOBAL MARKET SHARES FOR CONTRAST AGENTS, BY IMAGING TECHNOLOGY,
2011 (%) 72
FIGURE 3 GLOBAL MARKET FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2010-2017
($ MILLIONS) 77
FIGURE 4 MARKET SHARE FOR IMAGING SYSTEMS, BY IMAGING TECHNOLOGY, 2011 (%) 78
FIGURE 5 GLOBAL MARKET FOR CONTRAST AGENTS, BY REGION, 2010-2017 ($ MILLIONS) 81
FIGURE 6 GLOBAL MARKET SHARE FOR CONTRAST AGENTS, BY REGION, 2011 (%) 82
FIGURE 7 GLOBAL MARKET FOR IMAGING SYSTEMS, BY REGION, 2010-2017 ($ MILLIONS) 86
FIGURE 8 GLOBAL MARKET SHARE FOR IMAGING SYSTEMS BY REGION, 2011 (%) 87
FIGURE 9 GLOBAL REVENUE FOR IMAGING CONTRAST AGENTS AND SYSTEMS USED FOR
VARIOUS DISEASES, 2010-2017 ($ MILLIONS) 92
FIGURE 10 GLOBAL REVENUE MARKET SHARE FOR IMAGING CONTRAST AGENTS AND
SYSTEMS USED FOR VARIOUS DISEASES, 2011 (%) 94
FIGURE 11 GLOBAL MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION,
2010-2017 ($ MILLIONS) 98
FIGURE 12 MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, 2011 (%) 99
FIGURE 13 GLOBAL MARKET FOR PET SYSTEMS, BY REGION, 2010-2017 ($ MILLIONS) 101
FIGURE 14 MARKET SHARE OF PET SYSTEMS BY REGION, 2011 (%) 102
FIGURE 15 GLOBAL REVENUE FOR PET IMAGING USED FOR VARIOUS DISEASES, 2010-2017
($ MILLIONS) 104
FIGURE 16 POSITRON EMISSION TOMOGRAPHY IMAGING MARKET SHARES, BY
APPLICATION, 2011 (%) 105
FIGURE 17 WORLDWIDE MARKET SHARES OF DIAGNOSTIC RADIOPHARMACEUTICALS, 2011
(%) 109
FIGURE 18 WORLDWIDE MARKET SHARES OF PET IMAGING SYSTEMS, 2011 (%) 111
FIGURE 19 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012 116
FIGURE 20 TOTAL NUMBER OF PATENTS FOR IMAGING MODALITIES FROM 2008-JULY 2012
(%) 116
FIGURE 21 NUMBER OF PATENTS BY IMAGING MODALITY FROM JANUARY 2008-JULY 2012 117
FIGURE 22 NUMBER OF PATENTS BY COUNTRY FROM 2008-JULY 2012 120
FIGURE 23 NUMBER OF PATENTS BY ASSIGNEE FROM 2008-JULY 2012 121

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Global Diagnostic Imaging Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

Global Diagnostic Imaging Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

  • $ 14500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Ultrasound Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions

Ultrasound Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions

  • $ 12500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,850.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Global Ultrasound Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

Global Ultrasound Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

  • $ 12500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,850.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.